|
GB9423910D0
(en)
*
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
|
IL120266A
(en)
|
1996-02-28 |
2005-05-17 |
Pfizer |
Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
|
|
GB9612514D0
(en)
*
|
1996-06-14 |
1996-08-14 |
Pfizer Ltd |
Novel process
|
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
|
SK285991B6
(sk)
|
1997-04-25 |
2008-01-07 |
Pfizer Inc. |
Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
BR9909808A
(pt)
|
1998-04-20 |
2000-12-26 |
Pfizer |
Pirazolopirimidinonas inibidoras de cgmp pde5 para o tratamento da disfunção sexual
|
|
DE19827640A1
(de)
|
1998-06-20 |
1999-12-23 |
Bayer Ag |
7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
|
|
GB9822238D0
(en)
*
|
1998-10-12 |
1998-12-09 |
Pfizer Ltd |
Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
|
|
GB9823102D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
GB9823103D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
GB9823101D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
RU2220145C2
(ru)
*
|
1998-11-11 |
2003-12-27 |
Донг А Фарм. Ко., Лтд. |
Производные пиразолопиримидинона для лечения импотенции и способ их получения
|
|
KR100353014B1
(ko)
*
|
1998-11-11 |
2002-09-18 |
동아제약 주식회사 |
발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
|
|
US6225315B1
(en)
|
1998-11-30 |
2001-05-01 |
Pfizer Inc |
Method of treating nitrate-induced tolerance
|
|
WO2000066114A1
(en)
*
|
1999-04-30 |
2000-11-09 |
Lilly Icos Llc |
Treatment of female arousal disorder
|
|
MXPA00003997A
(es)
*
|
1999-04-30 |
2002-03-08 |
Lilly Icos Llc |
Articulos de fabricacion.
|
|
DE69904025T2
(de)
*
|
1999-06-04 |
2003-07-31 |
The Jordanian Pharmaceutical Manufacturing And Medical Equipment Co. Ltd., Jo-Naor |
Kondensierte Pyrimidinderivate und diese enthaltende pharmazeutische Zubereitungen
|
|
JP3145364B2
(ja)
|
1999-06-04 |
2001-03-12 |
ザ・ヨルダニアン・フアーマシユーテイカル・エム・エフ・ジー・アンド・メデイカル・イクイツプメント・カンパニー・リミテツド |
新規化合物及び該化合物を含有する医薬組成物
|
|
ES2166270B1
(es)
|
1999-07-27 |
2003-04-01 |
Almirall Prodesfarma Sa |
Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
|
|
DE19942474A1
(de)
*
|
1999-09-06 |
2001-03-15 |
Merck Patent Gmbh |
Pyrazolo[4,3-d]pyrimidine
|
|
US6350751B1
(en)
|
1999-10-11 |
2002-02-26 |
Pfizer Inc. |
Therapeutic agents
|
|
GB9923968D0
(en)
*
|
1999-10-11 |
1999-12-15 |
Pfizer Ltd |
Therapeutic agents
|
|
YU59100A
(sh)
*
|
1999-10-11 |
2003-10-31 |
Pfizer Inc. |
Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
|
|
TWI265925B
(en)
*
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
|
CZ20021151A3
(cs)
|
1999-10-11 |
2003-03-12 |
Pfizer Inc. |
5-(2-substituovaný-5-heterocyklylsulfonylpyrid-3-yl)-dihydropyrazolo[4,3-d]-pyrimidin-7-ony jako inhibitory fosfodiesterasy
|
|
TW200400821A
(en)
*
|
1999-11-02 |
2004-01-16 |
Pfizer |
Pharmaceutical composition (II) useful for treating or preventing pulmonary hypertension in a patient
|
|
AU2841801A
(en)
|
1999-12-24 |
2001-07-09 |
Bayer Aktiengesellschaft |
Triazolotriazinones and the use thereof
|
|
BR0017043A
(pt)
*
|
1999-12-24 |
2003-01-07 |
Bayer Ag |
Imidazo[1,3,5]triazinonas e sua aplicação
|
|
KR100358083B1
(ko)
*
|
2000-02-17 |
2002-10-25 |
에스케이케미칼주식회사 |
피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
|
|
AU2000254308A1
(en)
*
|
2000-05-17 |
2001-11-26 |
Sk Chemicals Co., Ltd. |
Pyrazolopyrimidinone derivatives, process for their preparation and their use
|
|
KR100377782B1
(ko)
*
|
2000-06-23 |
2003-03-29 |
동아제약 주식회사 |
발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법
|
|
US6407259B1
(en)
|
2000-07-28 |
2002-06-18 |
Pfizer Inc. |
Process for the preparation of pyrazoles
|
|
EP1176142A1
(en)
*
|
2000-07-28 |
2002-01-30 |
Pfizer Inc. |
Process for the preparation of pyrazoles
|
|
EP1307183A2
(en)
*
|
2000-08-11 |
2003-05-07 |
Pfizer Limited |
Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
|
|
PE20020394A1
(es)
|
2000-08-18 |
2002-06-21 |
Agouron Pharma |
Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
|
|
WO2002016364A1
(en)
*
|
2000-08-23 |
2002-02-28 |
Lg Life Sciences Ltd. |
Polyethoxylated pyrazolo pyrimidinone derivatives, process for preparation thereof and pharmaceutical compositions comprising the same for the treatment of impotence
|
|
US6821978B2
(en)
|
2000-09-19 |
2004-11-23 |
Schering Corporation |
Xanthine phosphodiesterase V inhibitors
|
|
GB0025782D0
(en)
*
|
2000-10-20 |
2000-12-06 |
Pfizer Ltd |
Use of inhibitors
|
|
US6548508B2
(en)
|
2000-10-20 |
2003-04-15 |
Pfizer, Inc. |
Use of PDE V inhibitors for improved fecundity in mammals
|
|
SE0004780D0
(sv)
|
2000-12-22 |
2000-12-22 |
Jordanian Pharmaceutical Mfg & |
Novel compunds
|
|
MXPA04004370A
(es)
|
2001-11-09 |
2004-08-11 |
Schering Corp |
Derivados policiclicos de guanina inhibidores de fosfodiesterasa v.
|
|
GB0129274D0
(en)
*
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Novel kit
|
|
EP1348707B1
(en)
*
|
2002-03-28 |
2010-08-25 |
Ustav Experimentalni Botaniky AV CR, v.v.i. (Institute of Experimental Botany Academy of Sciences of the Czech Republic, PRO) |
Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
|
|
GB0219961D0
(en)
|
2002-08-28 |
2002-10-02 |
Pfizer Ltd |
Oxytocin inhibitors
|
|
US7323462B2
(en)
|
2002-12-10 |
2008-01-29 |
Pfizer Inc. |
Morpholine dopamine agonists
|
|
JP2006511606A
(ja)
|
2002-12-13 |
2006-04-06 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
下部尿路症状を治療するα−２−δリガンド
|
|
EP1620437B1
(en)
|
2003-04-29 |
2009-06-17 |
Pfizer Limited |
5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
|
|
AU2004261459B2
(en)
|
2003-07-22 |
2008-06-26 |
Astex Therapeutics Limited |
3, 4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
US7291640B2
(en)
|
2003-09-22 |
2007-11-06 |
Pfizer Inc. |
Substituted triazole derivatives as oxytocin antagonists
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
EP1779852A3
(en)
*
|
2004-01-05 |
2007-05-09 |
Teva Pharmaceutical Industries Ltd. |
Processes for the production of sildenafil base and citrate salt
|
|
CA2552003A1
(en)
*
|
2004-01-05 |
2005-07-28 |
Teva Pharmaceutical Industries Ltd. |
Methods for the production of sildenafil base and citrate salt
|
|
WO2005079808A1
(en)
|
2004-01-22 |
2005-09-01 |
Pfizer Limited |
Triazole derivatives which inhibit vasopressin antagonistic activity
|
|
US7649002B2
(en)
|
2004-02-04 |
2010-01-19 |
Pfizer Inc |
(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
|
|
CA2562244A1
(en)
*
|
2004-04-07 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
|
ES2317209T3
(es)
|
2004-04-07 |
2009-04-16 |
Pfizer Inc. |
Pirazolo(4,3-) pirimidinas.
|
|
EP1786428B1
(en)
|
2004-08-17 |
2012-05-16 |
The Johns Hopkins University |
Pde5 inhibitor compositions and methods for treating cardiac indications
|
|
TWI367098B
(en)
*
|
2004-12-23 |
2012-07-01 |
Kowa Co |
Treating agent for glaucoma
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
WO2006100557A1
(en)
|
2005-03-21 |
2006-09-28 |
Pfizer Limited |
Substituted triazole derivatives as oxytocin antagonists
|
|
US8648100B2
(en)
|
2005-04-19 |
2014-02-11 |
Takeda Gmbh |
Roflumilast for the treatment of pulmonary hypertension
|
|
US8506934B2
(en)
|
2005-04-29 |
2013-08-13 |
Robert I. Henkin |
Methods for detection of biological substances
|
|
NZ564187A
(en)
|
2005-05-12 |
2010-03-26 |
Pfizer |
Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
|
|
BRPI0618643A2
(pt)
|
2005-11-09 |
2011-09-06 |
Combinatorx Inc |
composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
|
|
CA2634019A1
(en)
*
|
2005-12-20 |
2007-06-28 |
Pfizer Products Inc. |
Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist
|
|
GB0601951D0
(en)
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
|
WO2008095136A2
(en)
|
2007-01-31 |
2008-08-07 |
Henkin Robert I |
Methods for detection of biological substances
|
|
US8580801B2
(en)
|
2008-07-23 |
2013-11-12 |
Robert I. Henkin |
Phosphodiesterase inhibitor treatment
|
|
CN101747282A
(zh)
|
2008-12-10 |
2010-06-23 |
上海特化医药科技有限公司 |
一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
|
|
EP2379076B1
(en)
|
2008-12-23 |
2014-11-12 |
The Trustees of Columbia University in the City of New York |
Phosphodiesterase inhibitors and uses thereof
|
|
GB0903493D0
(en)
|
2009-02-27 |
2009-04-08 |
Vantia Ltd |
New compounds
|
|
TWI462739B
(zh)
|
2010-11-02 |
2014-12-01 |
Univ Kaohsiung Medical |
Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
|
|
NZ608903A
(en)
|
2010-11-03 |
2014-06-27 |
Dow Agrosciences Llc |
Pesticidal compositions and processes related thereto
|
|
CN102134242B
(zh)
*
|
2011-01-21 |
2013-08-28 |
浙江大德药业集团有限公司 |
一种用于治疗阳痿的快速长效的化合物
|
|
JP2014526461A
(ja)
*
|
2011-09-09 |
2014-10-06 |
エスケー ケミカルズ カンパニー，リミテッド |
Ｐｄｅ５抑制剤を含む皮膚しわ改善用組成物
|
|
RU2605537C2
(ru)
|
2011-10-26 |
2016-12-20 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Пестицидные композиции и способы, относящиеся к ним
|
|
US9402877B2
(en)
|
2011-11-04 |
2016-08-02 |
Xion Pharmaceuticals Corporation |
Methods and compositions for oral administration of melanocortin receptor agonist compounds
|
|
US20150119399A1
(en)
|
2012-01-10 |
2015-04-30 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
|
WO2013109738A1
(en)
|
2012-01-17 |
2013-07-25 |
The Trustees Of Columbia University In The City Of New York |
Novel phosphodiesterase inhibitors and uses thereof
|
|
US9708288B2
(en)
|
2012-04-27 |
2017-07-18 |
Dow Agrosciences Llc |
Pesticidal compositions and processes related thereto
|
|
US9282739B2
(en)
|
2012-04-27 |
2016-03-15 |
Dow Agrosciences Llc |
Pesticidal compositions and processes related thereto
|
|
CN104378986B
(zh)
|
2012-04-27 |
2017-05-31 |
陶氏益农公司 |
杀虫组合物和与其相关的方法
|
|
US20150297601A1
(en)
|
2012-10-05 |
2015-10-22 |
Robert I. Henkin |
Phosphodiesterase inhibitor treatment
|
|
US9789126B2
(en)
|
2012-12-21 |
2017-10-17 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating calcific aortic valve stenosis
|
|
CN103265479B
(zh)
*
|
2013-06-14 |
2017-12-08 |
南开大学 |
一种6‑氯甲基烟酸叔丁酯的合成方法
|
|
EP3022205B1
(en)
|
2013-07-17 |
2020-02-05 |
The Trustees of Columbia University in the City of New York |
Novel phosphodiesterase inhibitors and uses thereof
|
|
KR20160075565A
(ko)
|
2013-10-17 |
2016-06-29 |
다우 아그로사이언시즈 엘엘씨 |
살충성 화합물의 제조 방법
|
|
KR20160074543A
(ko)
|
2013-10-17 |
2016-06-28 |
다우 아그로사이언시즈 엘엘씨 |
살충성 화합물의 제조 방법
|
|
WO2015058023A1
(en)
|
2013-10-17 |
2015-04-23 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
CN105636442B
(zh)
|
2013-10-17 |
2018-04-27 |
美国陶氏益农公司 |
制备杀虫化合物的方法
|
|
CN105636440A
(zh)
|
2013-10-17 |
2016-06-01 |
美国陶氏益农公司 |
制备杀虫化合物的方法
|
|
KR20160072154A
(ko)
|
2013-10-17 |
2016-06-22 |
다우 아그로사이언시즈 엘엘씨 |
살충성 화합물의 제조 방법
|
|
WO2015058020A1
(en)
|
2013-10-17 |
2015-04-23 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
CA2926101C
(en)
|
2013-10-22 |
2022-05-31 |
Dow Agrosciences Llc |
Pesticidal compositions and related methods
|
|
AR098096A1
(es)
|
2013-10-22 |
2016-05-04 |
Dow Agrosciences Llc |
Composiciones plaguicidas sinérgicas y métodos relacionados
|
|
RU2016119553A
(ru)
|
2013-10-22 |
2017-12-04 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Синергетические пестицидные композиции и связанные с ними способы
|
|
CA2927206A1
(en)
|
2013-10-22 |
2015-04-30 |
Dow Agrosciences Llc |
Synergistic pesticidal compositions and related methods
|
|
TW201519783A
(zh)
|
2013-10-22 |
2015-06-01 |
Dow Agrosciences Llc |
殺蟲組成物及相關方法（四）
|
|
US9474276B2
(en)
|
2013-10-22 |
2016-10-25 |
Dow Agrosciences Llc |
Synergistic pesticidal compositions and related methods
|
|
US9295260B2
(en)
|
2013-10-22 |
2016-03-29 |
Dow Agrosciences Llc |
Pesticidal compositions and related methods
|
|
EP3060047A4
(en)
|
2013-10-22 |
2017-04-26 |
Dow AgroSciences, LLC |
Pesticidal compositions and related methods
|
|
CN108812681B
(zh)
|
2013-10-22 |
2021-02-26 |
美国陶氏益农公司 |
杀虫组合物和与其相关的方法
|
|
EP3094183A4
(en)
|
2013-10-22 |
2017-08-09 |
Dow AgroSciences LLC |
Synergistic pesticidal compositions and related methods
|
|
EP3060050A4
(en)
|
2013-10-22 |
2017-04-05 |
Dow AgroSciences LLC |
Synergistic pesticidal compositions and related methods
|
|
AU2014340414B2
(en)
|
2013-10-22 |
2017-09-07 |
Dow Agrosciences Llc |
Synergistic pesticidal compositions and related methods
|
|
CN105828611A
(zh)
|
2013-10-22 |
2016-08-03 |
美国陶氏益农公司 |
协同杀虫组合物和相关方法
|
|
KR20160074583A
(ko)
|
2013-10-22 |
2016-06-28 |
다우 아그로사이언시즈 엘엘씨 |
상승작용적 살충 조성물 및 관련 방법
|
|
JP2016535733A
(ja)
|
2013-10-22 |
2016-11-17 |
ダウ アグロサイエンシィズ エルエルシー |
相乗的有害生物防除組成物および関連する方法
|
|
RU2016119530A
(ru)
|
2013-10-22 |
2017-11-28 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Синергетические пестицидные композиции и относящиеся к ним способы
|
|
RU2656894C2
(ru)
|
2013-10-22 |
2018-06-07 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Пестицидные композиции и соответствующие способы
|
|
WO2015126944A1
(en)
|
2014-02-18 |
2015-08-27 |
Henkin Robert I |
Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
|
|
BR112017000418A2
(pt)
|
2014-07-31 |
2017-11-07 |
Dow Agrosciences Llc |
processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina
|
|
KR20170039121A
(ko)
|
2014-07-31 |
2017-04-10 |
다우 아그로사이언시즈 엘엘씨 |
3-(3-클로로-1h-피라졸-1-일)피리딘의 제조 방법
|
|
EP3174856A4
(en)
|
2014-07-31 |
2018-01-10 |
Dow AgroSciences LLC |
Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine
|
|
JP2017525703A
(ja)
|
2014-08-19 |
2017-09-07 |
ダウ アグロサイエンシィズ エルエルシー |
３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの調製方法
|
|
JP2017528469A
(ja)
|
2014-09-12 |
2017-09-28 |
ダウ アグロサイエンシィズ エルエルシー |
３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの調製方法
|
|
KR102332957B1
(ko)
*
|
2014-09-17 |
2021-11-29 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
화합물 및 방법
|
|
WO2016145614A1
(en)
|
2015-03-17 |
2016-09-22 |
Merck Sharp & Dohme Corp. |
Triazolyl pyrimidinone compounds as pde2 inhibitors
|
|
WO2016183741A1
(en)
|
2015-05-15 |
2016-11-24 |
Merck Sharp & Dohme Corp. |
Pyrimidinone amide compounds as pde2 inhibitors
|
|
KR20230038807A
(ko)
|
2016-09-09 |
2023-03-21 |
인사이트 코포레이션 |
Hpk1 조절제로서의 피라졸로피리딘 유도체 및 암의 치료를 위한 이의 용도
|
|
WO2018049152A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyrimidine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
|
WO2018125817A1
(en)
|
2016-12-29 |
2018-07-05 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
CN110139853B
(zh)
|
2016-12-29 |
2023-06-16 |
美国陶氏益农公司 |
用于制备杀有害生物化合物的方法
|
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
KR20200133747A
(ko)
|
2018-02-20 |
2020-11-30 |
인사이트 코포레이션 |
암을 치료하기 위한 hpk1 억제제로서의 n-(페닐)-2-(페닐)피리미딘-4-카복스아미드 유도체 및 관련 화합물
|
|
WO2019164847A1
(en)
|
2018-02-20 |
2019-08-29 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
|
ES2973117T3
(es)
|
2018-09-25 |
2024-06-18 |
Incyte Corp |
Compuestos de pirazolo[4,3-d]pirimidina como moduladores de ALK2 y/o FGFR
|
|
IL282618B2
(en)
*
|
2018-11-28 |
2025-05-01 |
Topadur Pharma Ag |
Novel dual-action soluble guanylate cyclase activators and phosphodiesterase inhibitors and their uses
|
|
JP2022526621A
(ja)
|
2019-04-10 |
2022-05-25 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
心血管機能障害の性別依存性処置のための方法及び材料
|
|
PE20221419A1
(es)
|
2019-08-06 |
2022-09-20 |
Incyte Corp |
Formas solidas de un inhibidor de hpk1
|
|
US12569493B2
(en)
|
2020-03-24 |
2026-03-10 |
Cyrano Therapeutics Inc. |
Treatment of chemosensory dysfunction from a coronavirus infection
|
|
CN113493459B
(zh)
*
|
2020-04-07 |
2022-12-13 |
广州白云山医药集团股份有限公司白云山制药总厂 |
Pde5抑制剂化合物及其制备方法和应用
|
|
CN113754612B
(zh)
*
|
2021-10-26 |
2023-09-26 |
山东安舜制药有限公司 |
一种西地那非中间体的制备方法
|
|
CN115785101B
(zh)
*
|
2022-11-23 |
2023-10-13 |
西安市食品药品检验所 |
一种含有苯基哌嗪结构的那非类化合物及其制备方法
|
|
CN116332856A
(zh)
*
|
2023-01-04 |
2023-06-27 |
荟达医药科技(上海)有限公司 |
一种4-哒嗪甲醇的合成方法
|